Aflac Incorporated (NYSE:AFL) Shares Sold by Telos Capital Management Inc.

Telos Capital Management Inc. cut its stake in shares of Aflac Incorporated (NYSE:AFL) by 5.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,055 shares of the financial services provider’s stock after selling 1,027 shares during the period. Telos Capital Management Inc.’s holdings in Aflac were worth $1,407,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BKM Wealth Management LLC acquired a new stake in Aflac during the 4th quarter valued at $1,558,000. Nordea Investment Management AB raised its position in shares of Aflac by 25.9% in the 4th quarter. Nordea Investment Management AB now owns 1,693,249 shares of the financial services provider’s stock worth $139,676,000 after buying an additional 348,400 shares during the period. G&S Capital LLC raised its position in shares of Aflac by 65.1% in the 4th quarter. G&S Capital LLC now owns 31,825 shares of the financial services provider’s stock worth $2,626,000 after buying an additional 12,551 shares during the period. DekaBank Deutsche Girozentrale raised its position in shares of Aflac by 7.5% in the 4th quarter. DekaBank Deutsche Girozentrale now owns 376,087 shares of the financial services provider’s stock worth $30,786,000 after buying an additional 26,338 shares during the period. Finally, Kestra Private Wealth Services LLC raised its position in shares of Aflac by 12.7% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 48,745 shares of the financial services provider’s stock worth $3,741,000 after buying an additional 5,477 shares during the period. 67.44% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the transaction, the director now directly owns 17,920 shares in the company, valued at $1,516,390.40. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the sale, the director now owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Masatoshi Koide sold 30,493 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the transaction, the director now owns 86,090 shares in the company, valued at approximately $6,879,451.90. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 46,493 shares of company stock worth $3,765,706. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

AFL has been the topic of several analyst reports. Wells Fargo & Company dropped their target price on Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a report on Thursday, April 11th. Raymond James boosted their price objective on Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. StockNews.com downgraded Aflac from a “hold” rating to a “sell” rating in a research note on Wednesday, April 10th. Morgan Stanley boosted their price objective on Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Monday. Finally, Keefe, Bruyette & Woods boosted their target price on Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a research report on Wednesday, April 10th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $82.15.

Aflac Price Performance

Shares of NYSE AFL opened at $80.26 on Thursday. The stock has a market capitalization of $46.18 billion, a price-to-earnings ratio of 10.36, a PEG ratio of 2.21 and a beta of 0.91. The business has a 50-day moving average of $82.06 and a 200-day moving average of $81.46. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a return on equity of 17.59% and a net margin of 24.92%. The business had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. During the same quarter in the previous year, the business posted $1.29 EPS. As a group, sell-side analysts predict that Aflac Incorporated will post 6.41 earnings per share for the current fiscal year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.